Sanofi SNY reported third-quarter 2024 adjusted earnings of $1.57 per American depositary share, which beat the Zacks ...

The focal points of the events were artificial intelligence and global market developments and innovations for air cargo and ...

The Wuzhen Summit of the 2024 World Internet Conference will be held in Wuzhen, Zhejiang Province, China, from November 19 to 22. On October 24, the World Internet Conference International ...

Galderma (SWX:GALD), the pure-play dermatology category leader, today announced a new edition of the Galderma Aesthetic ...

The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. The pharmacist ...

Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...

The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, ...

Sanofi (SNY) stock gains as company exceeds Q3 earnings estimates with strong vaccine and Dupixent sales, and raises its full ...

Sanofi (EPA:SASY) shares rose on Friday after the pharmaceutical giant posted better-than-expected third-quarter results, buoyed by strong vaccine revenues and robust early sales of Beyfortus, its ...

Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat ...

Sanofi is nearing a sale of a 50% stake in its consumer unit, valued at 16 billion euros in total, to boost clinical trials ...

Sales rose 12% to 13.44 billion euros on the continued strength of its anti-inflammatory drug Dupixent and sales in its pharma segment, which offset currency headwinds. Analysts expected business ...